Results 121 to 130 of about 17,262,511 (380)

Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset [PDF]

open access: yes, 2006
<p><b>Background and Purpose:</b> Desmoteplase is a novel plasminogen activator with favorable features in vitro compared with available agents.
Al, R.Y.   +9 more
core   +1 more source

Depression: An actionable outcome for those at clinical high-risk

open access: green, 2022
J. Addington   +15 more
openalex   +1 more source

Psychological Safety Among Interprofessional Pediatric Oncology Teams in Germany: A Nationwide Survey

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Psychological safety (PS) is essential for teamwork, communication, and patient safety in complex healthcare environments. In pediatric oncology, interprofessional collaboration occurs under high emotional and organizational demands. Low PS may increase stress, burnout, and adverse events.
Alexandros Rahn   +4 more
wiley   +1 more source

Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome

open access: yesNature Microbiology, 2021
I. Sulaiman   +51 more
semanticscholar   +1 more source

Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma

open access: yesOncoimmunology, 2015
Neuroblastoma grows within an intricate network of different cell types including epithelial, stromal and immune cells. The presence of tumor-infiltrating T cells is considered an important prognostic indicator in many cancers, but the role of these ...
Marco Mina   +9 more
semanticscholar   +1 more source

Developmental Disorders in Children Recently Diagnosed With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Neurocognitive deficits in adult survivors of childhood cancer are well established, but less is known about developmental disorders (DD) arising shortly after cancer diagnosis. Using 2016–2019 linked Ohio cancer registry and Medicaid data, we compared DD among 324 children with cancer and 606,913 cancer‐free controls.
Jamie Shoag   +5 more
wiley   +1 more source

Incidence and Effects of Polypharmacy on Clinical Outcome among Patients Aged 80+: A Five-Year Follow-Up Study

open access: yesPLoS ONE, 2015
Objectives Polypharmacy is a problem of growing interest in geriatrics with the increase in drug consumption in recent years, is defined according to the WHO criteria as the, ‘‘concurrent use of five or more different prescription medication”.
Rong Wang   +7 more
semanticscholar   +1 more source

Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background B‐acute lymphoblastic leukemia (B‐ALL) is the most common pediatric cancer, and while most children in high‐resource settings are cured, therapy carries risks for long‐term toxicities. Understanding parents’ concerns about these late effects is essential to guide anticipatory support and inform evolving therapeutic approaches ...
Kellee N. Parker   +7 more
wiley   +1 more source

Demography and clinical outcome of pulmonary tuberculosis in Kashmir; 2 year prospective study

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2016
Introduction: Tuberculosis (TB) is caused by Mycobacterium tuberculosis, primarily affecting lungs. One-third of the world’s population is currently infected with the TB bacillus. Tuberculosis is one of the three primary diseases of poverty.
Ajaz Nabi Koul   +5 more
doaj   +1 more source

The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice

open access: yesPatient Related Outcome Measures, 2019
This review article considers the rising demand for patient-reported outcome measures (PROMs) in modern ophthalmic research and clinical practice.
T. Braithwaite   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy